معرفی
Prof. Allen Cheng is a Professor/Director of Monash Infectious Diseases at Monash Health and holds a concurrent role as Director of the Infection Prevention and Healthcare Epidemiology Unit at Alfred Hospital. He holds advanced degrees including a PhD (Flinders University), Master of Public Health (Monash University), and Master of Biostatistics (University of Queensland). His research focuses on infectious diseases, including sepsis, influenza, antimicrobial resistance, and infection control. He has published over 400 peer-reviewed articles and contributed to national and international guidelines, including WHO protocols for sepsis management and pandemic response.
Education:
- PhD, Flinders University
- Master of Public Health, Monash University
- Master of Biostatistics, University of Queensland
Research Interests: Prof. Cheng’s work spans diverse areas within infectious diseases, emphasizing clinical epidemiology, vaccine effectiveness, and antimicrobial policy. His research addresses practical challenges in infection prevention, hospital-acquired pathogens, and global health crises like the 2020 pandemic.
Recent Article Trends: His publications from 2023–2025 highlight advancements in infection control strategies, vaccine efficacy studies, and pandemic management. Key themes include optimizing cleaning protocols for medical equipment, evaluating antibiotic stewardship, and analyzing long-term outcomes of SARS-CoV-2 infections.
Awards:
- Companion of the Order of Australia (2025)
- NHMRC Excellence Award (2014)
- Victorian Public Healthcare Award (2013)
- Frank Fenner Award (2012)
Advisory Roles & Grants: He has advised Australia’s health policy during the pandemic, including roles as Deputy Chief Health Officer (2020–2021) and Co-Chair of ATAGI. His grants support large-scale trials like the CLEEN study (cleaning protocols) and influenza vaccine effectiveness projects. Collaborations span institutions like Alfred Health, NHMRC, and WHO.
Labs/Teams: Leads infection prevention units at Monash and Alfred Hospitals, coordinating multidisciplinary teams in clinical trials and guideline development.
